AnaptysBio Inc. (ANAB)

68.58 +4.09 (+6.342%)

IEX Real-Time Price

November 16, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 64.49

Price Open 63.59

Volume: 400,589

Avg Volume: 383,211

Market Cap: 1.83B

P/E Ratio -31.75

52 Wk Range 62.56-134



ANAB Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
23.49M
2.89M
4.91
12.31%

2018-09-28
23.63M
2.65M
5.47
11.22%

2018-09-14
23.63M
2.33M
8.43
9.87%

2018-08-31
23.63M
2.32M
7.72
9.83%




ANAB Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-08
Q3 2018
N/A
-0.69 (4)
-0.66
0.03

2018-08-07
Q2 2018
N/A
-0.71 (3)
-0.57
0.14

2018-05-10
Q1 2018
N/A
-0.44 (4)
0.00
0.00

2018-05-08
Q1 2018
N/A
-0.44 (4)
-0.63
-0.19

News

AnaptysBio beats by $0.06, misses on revenue (2018-11-08 16:56 SeekingAlpha)

AnaptysBio (NASDAQ: ANAB ): Q3 GAAP EPS of -$0.66 beats by $0.06 . More news on: AnaptysBio, Earnings news and commentary, Healthcare stocks news, Read more …

 


Statistics

Shares Outstanding: 26.75M

Top 15 Institution Percent: 155.00

Price To Sales: 215.65

Price To Book: 3.45

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -15.97

Return On Equity: -17.14

Profit Margin: N/A

Price History

Beta: 3.48

50-day Moving Avg: 83.18

200-day Moving Avg: 88.97

YTD Change: -31.82

5-day Change: -2.86

1-month Change: -21.26

3-month Change: -16.49

6-month Change: -23.55

1-year Change: 2.21

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: AnaptysBio Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.anaptysbio.com

AnaptysBio Inc is a biotechnology company. The company is engaged in developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. Its product include ANB020 and ANB019.